FI782452A - Foerfarande foer framstaellning av 4-hydroxi-2-bentsimidazolinonderivat - Google Patents

Foerfarande foer framstaellning av 4-hydroxi-2-bentsimidazolinonderivat

Info

Publication number
FI782452A
FI782452A FI782452A FI782452A FI782452A FI 782452 A FI782452 A FI 782452A FI 782452 A FI782452 A FI 782452A FI 782452 A FI782452 A FI 782452A FI 782452 A FI782452 A FI 782452A
Authority
FI
Finland
Prior art keywords
framstation
hydroxi
benzimidazoline
containers
procedure
Prior art date
Application number
FI782452A
Other languages
English (en)
Finnish (fi)
Inventor
Carl Heinz Ross
Walter-Gunar Friebe
Wolfgang Kampe
Wolfgang Bartsch
Egon Roesch
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19782801953 external-priority patent/DE2801953A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI782452A publication Critical patent/FI782452A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI782452A 1977-08-12 1978-08-10 Foerfarande foer framstaellning av 4-hydroxi-2-bentsimidazolinonderivat FI782452A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2736295 1977-08-12
DE19782801953 DE2801953A1 (de) 1978-01-18 1978-01-18 4-hydroxy-2-benzimidazolinon-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
FI782452A true FI782452A (fi) 1979-02-13

Family

ID=25772515

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782452A FI782452A (fi) 1977-08-12 1978-08-10 Foerfarande foer framstaellning av 4-hydroxi-2-bentsimidazolinonderivat

Country Status (14)

Country Link
US (1) US4367235A (de)
EP (1) EP0000784B1 (de)
JP (1) JPS5432467A (de)
AT (1) AT364831B (de)
AU (1) AU3888578A (de)
CA (1) CA1108619A (de)
DD (1) DD137584A5 (de)
DE (1) DE2860981D1 (de)
DK (1) DK355378A (de)
ES (1) ES472435A1 (de)
FI (1) FI782452A (de)
IL (1) IL55315A0 (de)
IT (1) IT7826640A0 (de)
PT (1) PT68404A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178413A1 (de) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazole
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
JPS63156809A (ja) * 1986-12-19 1988-06-29 Shin Etsu Chem Co Ltd 塩化ビニル系重合体の製造方法
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
JPH09502166A (ja) * 1993-07-31 1997-03-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー アドレナリン受容体作動薬活性を有する２−ベンゾヘテロシクリルオキシまたはチオプロパノールアミン誘導体
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE215369T1 (de) 1996-09-05 2002-04-15 Lilly Co Eli Carbazolanaloge als selektive beta3-adrenergische agonisten
US5808080A (en) 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
CN103445428A (zh) * 2012-05-28 2013-12-18 苏州科羽电子技术服务有限公司 一种车座手提袋

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (de) * 1976-01-08 1981-07-31 Ciba Geigy Ag

Also Published As

Publication number Publication date
US4367235A (en) 1983-01-04
ES472435A1 (es) 1979-04-16
JPS5432467A (en) 1979-03-09
ATA582978A (de) 1981-04-15
IL55315A0 (en) 1978-10-31
DE2860981D1 (en) 1981-11-19
AT364831B (de) 1981-11-25
DK355378A (da) 1979-02-13
CA1108619A (en) 1981-09-08
DD137584A5 (de) 1979-09-12
PT68404A (de) 1978-09-01
AU3888578A (en) 1980-02-21
IT7826640A0 (it) 1978-08-09
EP0000784A1 (de) 1979-02-21
EP0000784B1 (de) 1981-08-26

Similar Documents

Publication Publication Date Title
SE7806323L (sv) Djupdragningsforfarande for framstellning av aluminiumbehallare
SE7802920L (sv) Forpackning av suturer
SE7808485L (sv) Forfarande for framstellning av oligoimider
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
SE7806729L (sv) Forfarande for framstellning av antikroppar
NO145837C (no) Fremgangsmaate for fremstilling av en voks-flegmatisk spengstoffblanding
SE7807240L (sv) Forfarande for framstellning av para-bensokinon
SE7707191L (sv) Forfaringssett for framstellning av behallare
SE7802667L (sv) Forfarande for bestemning av peroxidas
SE7809687L (sv) Forfarande for bestemning av cancerogena substanser
FI791562A (fi) Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat
FI782452A (fi) Foerfarande foer framstaellning av 4-hydroxi-2-bentsimidazolinonderivat
SE7902238L (sv) Forfarande for bestemning av alfa-amylas
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7801718L (sv) Kontinuerligt forfarande for framstellning av persyror
FI782574A (fi) Foerfarande foer framstaellning av n-substituerade 2-hydrazonopropionsyraderivat
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE7707114L (sv) Forfarande for framstellning av fast-tillstand-anordningar
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
FI783743A (fi) Foerfarande foer framstaellning av 3-di-n-propyl-acetoxi-benzodiazepin-2-oner
SE7706515L (sv) Forfarande for fornetning av plymerer
NO771576L (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid
NO149774C (no) Fremgangsmaate for fremstilling av et azetidinon

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BOEHRINGER MANNHEIM GMBH